Cambridge, MA, United States of America

Karin Pihel

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karin Pihel: Innovator in Thymus Tissue Engineering

Introduction

Karin Pihel, based in Cambridge, MA, is a notable inventor recognized for her significant contributions to the field of immunology and tissue engineering. With her innovative approach, she has developed a patent that holds promise for enhancing organ transplant procedures by utilizing cultured thymus tissue.

Latest Patents

Karin Pihel holds a patent titled "Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use." This patent encompasses a range of techniques and compositions aimed at promoting donor-specific tolerance and immunocompetence in recipients of solid organ transplants. It describes methods of implanting allogeneic solid organs while incorporating tissue-engineered cultured postnatal thymus tissues to optimize transplant success. Furthermore, the patent outlines processes for producing and culturing suitable thymus tissue-derived products for human implantation.

Career Highlights

Throughout her career, Karin Pihel has built a robust professional profile, having worked with renowned organizations such as Enzyvant Therapeutics GmbH and Duke University. Her tenure in these institutions has allowed her to refine her research skills and deepen her understanding of immunological applications in organ transplantation.

Collaborations

In pursuing her innovative research, Karin has collaborated with esteemed colleagues, including Mary Louise Markert and Laura P. Hale. Together, they have contributed to advancing the knowledge and techniques involved in the application of thymus tissue in transplant medicine.

Conclusion

Karin Pihel stands out as a leading figure in the field of thymus tissue engineering, making strides towards improving organ transplant outcomes. Her patented methodologies offer exciting prospects for fostering donor-specific tolerance in recipients, thereby enhancing the efficacy of solid organ transplants. As research in this area progresses, her contributions will undoubtedly continue to influence the future of immunological health and transplantation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…